- Home
- / Sinopharm Group
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Sinopharm Group financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$20
2024-10-29
Market Capitalization
$60.5 B
2024-10-29
Revenue
¥575.2 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 344.5B | 425.3B | 456.4B | 521.1B | 552.1B | 596.6B | 584.5B | 575.2B |
| Cost of goods sold | 313.0B | 386.0B | 414.1B | 474.8B | 502.3B | 545.4B | 537.4B | 529.2B |
| Gross profit | 31.9B | 39.7B | 43.0B | 46.9B | 50.5B | 51.7B | 47.6B | 46.4B |
| Gross profit margin, % | 9.3% | 9.3% | 9.4% | 9.0% | 9.1% | 8.7% | 8.1% | 8.1% |
| Operating expense total | 14.8B | 18.1B | 19.6B | 21.5B | 23.1B | 24.3B | 23.7B | 24.0B |
| Depreciation and amortization | 1.4B | 3.3B | 3.9B | 4.5B | 4.2B | 4.5B | 5.8B | 4.8B |
| EBITDA | 17.9B | 22.5B | 24.4B | 26.4B | 28.4B | 28.5B | 25.1B | 23.6B |
| EBITDA margin, % | 5.2% | 5.3% | 5.3% | 5.1% | 5.2% | 4.8% | 4.3% | 4.1% |
| EBIT | 16.6B | 16.9B | 18.7B | 21.6B | 24.2B | 24.6B | 17.8B | 18.9B |
| EBIT margin, % | 4.8% | 4.0% | 4.1% | 4.2% | 4.4% | 4.1% | 3.0% | 3.3% |
| Interest income | 513.4M | 519.4M | 676.4M | 558.6M | 542.8M | 743.4M | 617.0M | 500.2M |
| Interest expense | 4.6B | 3.7B | 3.6B | 4.0B | 3.7B | 3.2B | 2.9B | 2.5B |
| Pre tax profit | 12.2B | 13.8B | 15.6B | 17.0B | 18.6B | 19.5B | 14.0B | 14.8B |
| Income tax expense | 2.8B | 3.1B | 3.5B | 3.9B | 4.2B | 4.5B | 3.6B | 4.0B |
| Net Income | 9.4B | 10.6B | 12.1B | 13.1B | 14.3B | 15.0B | 10.4B | 10.8B |